1hzp

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1hzp" size="450" color="white" frame="true" align="right" spinBox="true" caption="1hzp, resolution 2.10&Aring;" /> '''Crystal Structure of...)
Line 1: Line 1:
-
[[Image:1hzp.gif|left|200px]]<br /><applet load="1hzp" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1hzp.gif|left|200px]]<br /><applet load="1hzp" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1hzp, resolution 2.10&Aring;" />
caption="1hzp, resolution 2.10&Aring;" />
'''Crystal Structure of the Myobacterium Tuberculosis Beta-Ketoacyl-Acyl Carrier Protein Synthase III'''<br />
'''Crystal Structure of the Myobacterium Tuberculosis Beta-Ketoacyl-Acyl Carrier Protein Synthase III'''<br />
==Overview==
==Overview==
-
Mycolic acids (alpha-alkyl-beta-hydroxy long chain fatty acids) cover the, surface of mycobacteria, and inhibition of their biosynthesis is an, established mechanism of action for several key front-line, anti-tuberculosis drugs. In mycobacteria, long chain acyl-CoA products, (C(14)-C(26)) generated by a type I fatty-acid synthase can be used, directly for the alpha-branch of mycolic acid or can be extended by a type, II fatty-acid synthase to make the meromycolic acid (C(50)-C(56)))-derived, component. An unusual Mycobacterium tuberculosis beta-ketoacyl-acyl, carrier protein (ACP) synthase III (mtFabH) has been identified, purified, and shown to catalyze a Claisen-type condensation between long chain, acyl-CoA substrates such as myristoyl-CoA (C(14)) and malonyl-ACP. This, enzyme, presumed to play a key role in initiating meromycolic acid, biosynthesis, was crystallized, and its structure was determined at 2.1-A, resolution. The mtFabH homodimer is closely similar in topology and, active-site structure to Escherichia coli FabH (ecFabH), with a, CoA/malonyl-ACP-binding channel leading from the enzyme surface to the, buried active-site cysteine residue. Unlike ecFabH, mtFabH contains a, second hydrophobic channel leading from the active site. In the ecFabH, structure, this channel is blocked by a phenylalanine residue, which, constrains specificity to acetyl-CoA, whereas in mtFabH, this residue is a, threonine, which permits binding of longer acyl chains. This same channel, in mtFabH is capped by an alpha-helix formed adjacent to a 4-amino acid, sequence insertion, which limits bound acyl chain length to 16 carbons., These observations offer a molecular basis for understanding the unusual, substrate specificity of mtFabH and its probable role in regulating the, biosynthesis of the two different length acyl chains required for, generation of mycolic acids. This mtFabH presents a new target for, structure-based design of novel antimycobacterial agents.
+
Mycolic acids (alpha-alkyl-beta-hydroxy long chain fatty acids) cover the surface of mycobacteria, and inhibition of their biosynthesis is an established mechanism of action for several key front-line anti-tuberculosis drugs. In mycobacteria, long chain acyl-CoA products (C(14)-C(26)) generated by a type I fatty-acid synthase can be used directly for the alpha-branch of mycolic acid or can be extended by a type II fatty-acid synthase to make the meromycolic acid (C(50)-C(56)))-derived component. An unusual Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein (ACP) synthase III (mtFabH) has been identified, purified, and shown to catalyze a Claisen-type condensation between long chain acyl-CoA substrates such as myristoyl-CoA (C(14)) and malonyl-ACP. This enzyme, presumed to play a key role in initiating meromycolic acid biosynthesis, was crystallized, and its structure was determined at 2.1-A resolution. The mtFabH homodimer is closely similar in topology and active-site structure to Escherichia coli FabH (ecFabH), with a CoA/malonyl-ACP-binding channel leading from the enzyme surface to the buried active-site cysteine residue. Unlike ecFabH, mtFabH contains a second hydrophobic channel leading from the active site. In the ecFabH structure, this channel is blocked by a phenylalanine residue, which constrains specificity to acetyl-CoA, whereas in mtFabH, this residue is a threonine, which permits binding of longer acyl chains. This same channel in mtFabH is capped by an alpha-helix formed adjacent to a 4-amino acid sequence insertion, which limits bound acyl chain length to 16 carbons. These observations offer a molecular basis for understanding the unusual substrate specificity of mtFabH and its probable role in regulating the biosynthesis of the two different length acyl chains required for generation of mycolic acids. This mtFabH presents a new target for structure-based design of novel antimycobacterial agents.
==About this Structure==
==About this Structure==
-
1HZP is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis] with DAO and GOL as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Beta-ketoacyl-acyl-carrier-protein_synthase_I Beta-ketoacyl-acyl-carrier-protein synthase I], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.1.41 2.3.1.41] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1HZP OCA].
+
1HZP is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis] with <scene name='pdbligand=DAO:'>DAO</scene> and <scene name='pdbligand=GOL:'>GOL</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Beta-ketoacyl-acyl-carrier-protein_synthase_I Beta-ketoacyl-acyl-carrier-protein synthase I], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.1.41 2.3.1.41] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HZP OCA].
==Reference==
==Reference==
Line 16: Line 16:
[[Category: He, X.]]
[[Category: He, X.]]
[[Category: Kazanina, G.]]
[[Category: Kazanina, G.]]
-
[[Category: Reynolds, K.A.]]
+
[[Category: Reynolds, K A.]]
-
[[Category: Scarsdale, J.N.]]
+
[[Category: Scarsdale, J N.]]
-
[[Category: TBSGC, TB.Structural.Genomics.Consortium.]]
+
[[Category: TBSGC, TB Structural Genomics Consortium.]]
-
[[Category: Wright, H.T.]]
+
[[Category: Wright, H T.]]
[[Category: DAO]]
[[Category: DAO]]
[[Category: GOL]]
[[Category: GOL]]
Line 31: Line 31:
[[Category: tbsgc]]
[[Category: tbsgc]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 16:56:13 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:06:28 2008''

Revision as of 11:06, 21 February 2008


1hzp, resolution 2.10Å

Drag the structure with the mouse to rotate

Crystal Structure of the Myobacterium Tuberculosis Beta-Ketoacyl-Acyl Carrier Protein Synthase III

Overview

Mycolic acids (alpha-alkyl-beta-hydroxy long chain fatty acids) cover the surface of mycobacteria, and inhibition of their biosynthesis is an established mechanism of action for several key front-line anti-tuberculosis drugs. In mycobacteria, long chain acyl-CoA products (C(14)-C(26)) generated by a type I fatty-acid synthase can be used directly for the alpha-branch of mycolic acid or can be extended by a type II fatty-acid synthase to make the meromycolic acid (C(50)-C(56)))-derived component. An unusual Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein (ACP) synthase III (mtFabH) has been identified, purified, and shown to catalyze a Claisen-type condensation between long chain acyl-CoA substrates such as myristoyl-CoA (C(14)) and malonyl-ACP. This enzyme, presumed to play a key role in initiating meromycolic acid biosynthesis, was crystallized, and its structure was determined at 2.1-A resolution. The mtFabH homodimer is closely similar in topology and active-site structure to Escherichia coli FabH (ecFabH), with a CoA/malonyl-ACP-binding channel leading from the enzyme surface to the buried active-site cysteine residue. Unlike ecFabH, mtFabH contains a second hydrophobic channel leading from the active site. In the ecFabH structure, this channel is blocked by a phenylalanine residue, which constrains specificity to acetyl-CoA, whereas in mtFabH, this residue is a threonine, which permits binding of longer acyl chains. This same channel in mtFabH is capped by an alpha-helix formed adjacent to a 4-amino acid sequence insertion, which limits bound acyl chain length to 16 carbons. These observations offer a molecular basis for understanding the unusual substrate specificity of mtFabH and its probable role in regulating the biosynthesis of the two different length acyl chains required for generation of mycolic acids. This mtFabH presents a new target for structure-based design of novel antimycobacterial agents.

About this Structure

1HZP is a Single protein structure of sequence from Mycobacterium tuberculosis with and as ligands. Active as Beta-ketoacyl-acyl-carrier-protein synthase I, with EC number 2.3.1.41 Full crystallographic information is available from OCA.

Reference

Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III., Scarsdale JN, Kazanina G, He X, Reynolds KA, Wright HT, J Biol Chem. 2001 Jun 8;276(23):20516-22. Epub 2001 Mar 8. PMID:11278743

Page seeded by OCA on Thu Feb 21 13:06:28 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools